Noxopharm to Present Sofra Study at LUPUS 2023 Conference miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Noxopharm Ltd (ASX:NOX) has been invited to present research from its inflammation-related SofraTM preclinical program in oral format at the upcoming 15th.
Helping pre-term babies avoid bronchopulmonary dysplasia by controlling immune responses miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
From long COVID to Alzheimer’s, all manner of health woes are increasingly thought to have inflammation in common. Now, great medical minds are on the case.
From long COVID to Alzheimer’s, all manner of health woes are increasingly thought to have inflammation in common. Now, great medical minds are on the case.